LC-MS/MS method for confirmation of recombinant human erythropoietin and darbepoetin alpha in equine plasma.

The research article entails the development of a novel method using LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) to confirm the presence of recombinant human erythropoietin (rhEPO) and darbepoetin alpha (DPO) in equine plasma. These drugs, commonly used to treat anemia, are at times abused in equine sports for performance enhancement. The new method has proved to be efficient, sensitive, and specific in detecting these prohibited substances in equine sports.

LC-MS/MS Detection Method

• The paper describes a method utilizing LC-MS/MS to detect and confirm rhEPO and DPO in horse plasma. LC-MS/MS is a technique that combines the physical separation capabilities of liquid chromatography (LC) with the mass analysis capabilities of mass spectrometry (MS). It’s a powerful tool in identifying the components of a sample.
• This method includes separation and enrichment of the target substances (rhEPO and DPO) using an immunoaffinity process with anti-rhEPO antibodies attached to magnetic beads. This step increases the concentration of analytes relative to other substances to increase detection sensitivity.
• In the next step, the samples are digested with trypsin – an enzyme that cuts proteins into smaller peptides. The resulting fragments are then analyzed using LC-MS/MS.

Confirmation of Analytes

• For confirming the substances, two specific “proteotypic” peptides (small pieces of the protein) were used. These peptides, 46VNFYAWK52 and 144VYSNFLR150, are specific to rhEPO and DPO.
• The method focuses on comparing the chromatographic retention times and the major product ions for each peptide, which would ensure the presence and identity of the drugs.

Performance of the Method

• The method has been effective in confirming the presence of rhEPO and DPO in equine plasma with high sensitivity. The limit of detection was as low as 0.1 ng/mL, and the limit of confirmation was 0.2 ng/mL, making it a highly sensitive detection method.
• The new methodology was successfully applied in real settings, with plasma samples from research horses and racehorses in competition and non-competition samples.

Impact on the Horse Racing Industry

• The mention of the method’s usability in the horse racing industry points to its potential in curbing the abuse of performance-enhancing drugs in the sport. By providing a reliable tool for detecting these substances, it assists in ensuring fair competition and animal welfare.
• The authors note that this method is the first of its kind for providing unambiguous confirmation of rhEPO and DPO in equine plasma, marking a notable contribution to drug testing methodologies in equine sports.